Related Experiment Video
Updated: Jun 2, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Endovascular therapy for hepatic artery stenosis and thrombosis following liver transplantation
Saher S Sabri1, Wael E A Saad, Timothy M Schmitt
1Division of Vascular and Interventional Radiology, Department of Radiology, University of Virginia Health System, Charlottesville, VA, USA.
Insights
Endovascular management effectively treats hepatic artery stenosis (HAS) in liver transplants, achieving high patency and survival rates. However, it is not effective for treating hepatic artery thrombosis (HAT).
Area of Science:
- Transplantation Surgery
- Vascular Surgery
- Interventional Radiology
Background:
- Hepatic artery stenosis (HAS) and thrombosis (HAT) are serious complications following liver transplantation.
- Vascular complications can significantly impact graft survival and patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of endovascular techniques for managing steno-occlusive disease in liver transplant recipients.
- To assess the outcomes of endovascular treatment for HAS and HAT.
Main Methods:
- Retrospective review of liver transplant patients diagnosed with HAS or HAT.
- Treatment strategies included balloon angioplasty with stenting for HAS and catheter-directed thrombolysis for HAT.
- Key outcome measures were primary, unassisted, and assisted patency rates, as well as graft survival.
Main Results:
- The study included 31 patients (81% with HAS, 19% with HAT).
- Endovascular procedures demonstrated a 91% technical success rate for HAS, with an 11% major complication rate.
- Primary-assisted patency and graft survival at 12 months were 81% and 72%, respectively.
- Successful thrombolysis for HAT was achieved in only one patient.
Conclusions:
- Endovascular management, including angioplasty and stenting, is an effective treatment for hepatic artery stenosis in liver transplant recipients.
- Catheter-directed thrombolysis is largely ineffective for treating hepatic artery thrombosis post-liver transplant.
Purpose:
To evaluate the effectiveness of endovascular management of steno-oclusive disease in liver transplants.
Methods:
Retrospective review of liver transplant recipients with hepatic artery stenosis (HAS) or thrombosis (HAT) was performed. The HAS group was treated with balloon angioplasty with selective stent placement. The HAT group was treated with catheter-directed thrombolysis. Primary, unassisted, and assisted patency and graft survival rates were calculated.
Results:
In all, 31 patients were identified (21 males; mean age, 51 years). A total of 25 of 31 (81%) patients had HAS and 6 of 31 (19%) had HAT. Collectively, a total of 35 endovascular procedures were performed to treat HAS in 25 patients. Overall technical success rate was 91%, with 11% major complication rate. Primary-assisted patency rate and graft survival at 6 and 12 months were 87% and 81%, and 76% and 72%, respectively. Only 1 successful thrombolysis of HAT was achieved.
Conclusion:
Endovascular management is effective for HAS but not for HAT.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care